Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00329264

Public ClinicalTrials.gov record NCT00329264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (SEROQUEL®) Compared With Placebo in the Treatment of Generalized Anxiety Disorder

Study identification

NCT ID
NCT00329264
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
876 participants

Conditions and interventions

Interventions

  • Quetiapine fumarate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Not listed
Completion
Jul 31, 2007
Last update posted
Mar 24, 2009

2006 – 2007

United States locations

U.S. sites
58
U.S. states
32
U.S. cities
58
Facility City State ZIP Site status
Research Site Springdale Arizona
Research Site Little Rock Arkansas
Research Site Encino California
Research Site Newport Beach California
Research Site Oceanside California
Research Site Redlands California
Research Site Santa Ana California
Research Site Denver Colorado
Research Site Norwich Connecticut
Research Site Washington D.C. District of Columbia
Research Site Fort Walton Beach Florida
Research Site Gainsville Florida
Research Site Hialeah Florida
Research Site Jacksonville Florida
Research Site Miami Florida
Research Site Orlando Florida
Research Site Tampa Florida
Research Site Winter Park Florida
Research Site Atlanta Georgia
Research Site Smyrna Georgia
Research Site Eagle Idaho
Research Site Chicago Illinois
Research Site Oak Brook Illinois
Research Site Indianapolis Indiana
Research Site Topeka Kansas
Research Site New Orleans Louisiana
Research SIte Fall River Massachusetts
Research Site Farmington Hills Michigan
Research Site Ridgeland Mississippi
Research Site St Louis Missouri
Research Site Las Vegas Nevada
Research Site Cherry Hill New Jersey
Research Site Clementon New Jersey
Research Site Brooklyn New York
Research Site New York New York
Research Site Rochester New York
Research Site Staten Island New York
Research Site Charlotte North Carolina
Research Site Durham North Carolina
Research Site Cincinnati Ohio
Research Site Toledo Ohio
Research Site Oklahoma City Oklahoma
Research Site Tulsa Oklahoma
Research Site Portland Oregon
Research Site Allentown Pennsylvania
Research Site Norristown Pennsylvania
Research Site Lincoln Rhode Island
Research Site Memphis Tennessee
Research Site Austin Texas
Research Site Dallas Texas
Research Site Friendswood Texas
Research Site San Antonio Texas
Research Site Woodstock Vermont
Research Site Herndon Virginia
Research Site Midlothian Virginia
Research Site Bellevue Washington
Research Site Seattle Washington
Research Site Charleston West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00329264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2009 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00329264 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →